ATE284405T1 - Neues verfahren zur herstellung von oxabispidinen - Google Patents

Neues verfahren zur herstellung von oxabispidinen

Info

Publication number
ATE284405T1
ATE284405T1 AT02718766T AT02718766T ATE284405T1 AT E284405 T1 ATE284405 T1 AT E284405T1 AT 02718766 T AT02718766 T AT 02718766T AT 02718766 T AT02718766 T AT 02718766T AT E284405 T1 ATE284405 T1 AT E284405T1
Authority
AT
Austria
Prior art keywords
sup
formula
compound
oxabispidines
producing
Prior art date
Application number
AT02718766T
Other languages
English (en)
Inventor
Lal Cheema
David Cladingboel
Rhona Sinclair
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE284405T1 publication Critical patent/ATE284405T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
AT02718766T 2001-04-12 2002-04-12 Neues verfahren zur herstellung von oxabispidinen ATE284405T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101324A SE0101324D0 (sv) 2001-04-12 2001-04-12 New process
PCT/SE2002/000727 WO2002083690A1 (en) 2001-04-12 2002-04-12 New process for the preparation of oxabispidines

Publications (1)

Publication Number Publication Date
ATE284405T1 true ATE284405T1 (de) 2004-12-15

Family

ID=20283781

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02718766T ATE284405T1 (de) 2001-04-12 2002-04-12 Neues verfahren zur herstellung von oxabispidinen

Country Status (19)

Country Link
US (2) US7169921B2 (de)
EP (1) EP1385850B1 (de)
JP (1) JP4248880B2 (de)
KR (1) KR100848613B1 (de)
CN (1) CN1267435C (de)
AT (1) ATE284405T1 (de)
AU (1) AU2002249748B2 (de)
BR (1) BR0208861A (de)
CA (1) CA2443475A1 (de)
DE (1) DE60202203T2 (de)
ES (1) ES2233809T3 (de)
IL (2) IL158249A0 (de)
MX (1) MXPA03009211A (de)
NO (1) NO20034526L (de)
NZ (1) NZ528515A (de)
PT (1) PT1385850E (de)
SE (1) SE0101324D0 (de)
WO (1) WO2002083690A1 (de)
ZA (1) ZA200307676B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0101324D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab New process
GB0223712D0 (en) 2002-10-14 2002-11-20 Astrazeneca Ab Chemical intermediate
US20040192738A1 (en) * 2003-03-18 2004-09-30 Aventis Pharma Deutschland Gmbh 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxypyridin-3-yl)propyl] benzamide, its use as a medicament, and pharmaceutical preparations comprising it
SE0401539D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401540D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
KR20080021114A (ko) * 2005-06-13 2008-03-06 아스트라제네카 아베 심부정맥의 치료를 위한 신규한 옥사비스피딘 화합물
WO2006134124A1 (en) * 2005-06-16 2006-12-21 Girindus Ag Synthesis of hydroquinone derivatives
JP2008546765A (ja) * 2005-06-20 2008-12-25 アストラゼネカ アクチボラグ (アルコキシカルボニルアミノ)−アルキルスルホネートの製造方法
KR20080028435A (ko) * 2005-06-20 2008-03-31 아스트라제네카 아베 N,n’-이치환된 옥사비스피딘의 제조 방법
AR054284A1 (es) * 2005-06-20 2007-06-13 Astrazeneca Ab Procedimiento para la preparacion de sales de acido sulfonico de oxabispidinas
AR053901A1 (es) * 2005-06-20 2007-05-23 Astrazeneca Ab Formas fisicas de oxabispidinas n,n'- disustituidas
AR057364A1 (es) * 2005-06-20 2007-11-28 Astrazeneca Ab Proceso para el aislamiento de 4-(oxiranilmetoxi) -benzonitrilos
AU2006259936B2 (en) * 2005-06-20 2010-08-12 Astrazeneca Ab Process for the preparation of 3,7-dihydroxy-1,5-diazacyclooctanes
JP6426694B2 (ja) 2013-03-15 2018-11-21 グローバル ブラッド セラピューティクス インコーポレイテッド ヘモグロビンの修飾のための化合物及びその使用
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3196154A (en) * 1962-05-17 1965-07-20 Sterling Drug Inc 3-substituted-9-methyl-3, 9-diazabicyclo [3.3.1] nonanes
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
SE9704709D0 (sv) * 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
SE0101324D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab New process

Also Published As

Publication number Publication date
BR0208861A (pt) 2004-10-19
JP4248880B2 (ja) 2009-04-02
KR20030087065A (ko) 2003-11-12
ZA200307676B (en) 2004-07-13
WO2002083690A1 (en) 2002-10-24
PT1385850E (pt) 2005-03-31
SE0101324D0 (sv) 2001-04-12
CN1520417A (zh) 2004-08-11
ES2233809T3 (es) 2005-06-16
US20070197519A1 (en) 2007-08-23
NZ528515A (en) 2005-06-24
NO20034526L (no) 2003-10-31
JP2004533432A (ja) 2004-11-04
US20040181060A1 (en) 2004-09-16
IL158249A0 (en) 2004-05-12
IL158249A (en) 2009-09-01
CA2443475A1 (en) 2002-10-24
KR100848613B1 (ko) 2008-07-28
US7169921B2 (en) 2007-01-30
NO20034526D0 (no) 2003-10-09
DE60202203T2 (de) 2005-12-15
HK1060886A1 (en) 2004-08-27
DE60202203D1 (de) 2005-01-13
MXPA03009211A (es) 2004-01-29
CN1267435C (zh) 2006-08-02
AU2002249748B2 (en) 2008-02-28
EP1385850B1 (de) 2004-12-08
EP1385850A1 (de) 2004-02-04

Similar Documents

Publication Publication Date Title
DE60202203D1 (de) Neues verfahren zur herstellung von oxabispidinen
DE602004025344D1 (de) Biologisch abbaubare verzweigte polylactidderivate, die zur bildung von polymermicellen befähigt sind, herstellungsverfahren dafür und verwendung davon
DE60233664D1 (de) Verfahren zur herstellung von pyridinverbindungen
DE60134472D1 (de) Oxidationsverfahren zur herstellung des zwischenproduktes 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpone 17.beta.-karbonsäure
DE50113943D1 (de) 4-alkoxy-cyclohexan-1-amino-carbonsäureester und verfahren zu ihrer herstellung
ATE261953T1 (de) Verfahren zur herstellung von citalopram
DE60219501D1 (de) Verfahren zur herstellung von 3-hydroxy-n-1,6-trialkyl-4-oxo-1,4-dihydropyridin-2-carboxamide
DE60010682D1 (de) Verfahren zur herstellung von zwischenprodukten für pestizide
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
ATE299862T1 (de) Verfahren zur herstellung von ketiminen
ATE540934T1 (de) Verfahren zur herstellung substituierter anilinverbindungen
ATE282594T1 (de) Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin
ATE300534T1 (de) Verfahren und zwischenverbindungen zur herstellung von imidazopyridinen
DE60014103D1 (de) Verfahren zur herstellung von debromohymenialdisin und deren analogen
DE50110250D1 (de) Verfahren zur herstellung von 3-aminoalkansäureestern
ATE229500T1 (de) Verfahren zur herstellung von trion- bis(oximether) derivaten sowie damit erhältliche trion-mono- und trion-bis(oximether) derivate
DE60142962D1 (de) Verfahren zur herstellung von pestiziden verbindungen
DE60114889D1 (de) Verfahren zur herstellung von fluconazole und kristallmodifikationen davon
ATE473213T1 (de) Verfahren zur herstellung von phenyl-2- pyrimidinyl-ketonen und neuen zwischenprodukten daraus
ATE391717T1 (de) Verfahren zur herstellung von 5-benzyl-3- furfurylalkohol
ATE394380T1 (de) Verfahren zur herstellung von (pyrimidin-2- yl)methylketonen
ATE297478T1 (de) Verfahren zur herstellung von orthocarbonsäuretrialkylestern
ATE321028T1 (de) Verfahren zur herstellung von 1,3- disubstituierten 2-nitroguanidinen
ATE388942T1 (de) Verfahren zur herstellung von 1-(pyrimidin-2- yl)propan-2-one derivaten
ATE247632T1 (de) Verfahren zur herstellung von cyanessigsäureestern

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1385850

Country of ref document: EP

REN Ceased due to non-payment of the annual fee